Browse by ["viewname_eprint_publisher" not defined]
![]() | Up a level |
- University of Regensburg (2)
- Medicine (2)
- Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) (2)
- Medicine (2)
W
Walter, Bernhard and Schrettenbrunner, I. and Vogelhuber, M. and Grassinger, J. and Bross, K. and Wilke, J. and Suedhoff, T. and Berand, A. and Wieland, W. F. and Rogenhofer, S. and Andreesen, R. and Reichle, A. (2012) Pioglitazone, etoricoxib, interferon-alpha, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial. MEDICAL ONCOLOGY, 29 (2). pp. 799-805. ISSN 1357-0560
Walter, I. and Schulz, U. and Vogelhuber, M. and Wiedmann, K. and Endlicher, E. and Klebl, F. and Andreesen, R. and Herr, W. and Ghibelli, L. and Hackl, C. and Wiest, R. and Reichle, A. (2017) Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial. MEDICAL ONCOLOGY, 34 (12): 192. ISSN 1357-0560, 1559-131X

